(2023)
Administering Antibiotics for Less Than Four Weeks Increases the Risk of Relapse in Culture-Positive Septic Arthritis of Native Joints.
JOURNAL OF CLINICAL MEDICINE.
12,
21
(2023)
Methicillin Resistance Increased the Risk of Treatment Failure in Native Joint Septic Arthritis Caused by <i>Staphylococcus aureus</i>.
ANTIBIOTICS-BASEL.
12,
11
(2023)
Glycaemic status, insulin resistance, and risk of infection-related mortality: a cohort study.
EUROPEAN JOURNAL OF ENDOCRINOLOGY.
188,
2
(2022)
Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor.
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY.
40,
4
(2022)
Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea.
JOURNAL OF KOREAN MEDICAL SCIENCE.
37,
22
(2022)
Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea.
Infection and Chemotherapy.
54,
2
(2022)
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
JOURNAL OF KOREAN MEDICAL SCIENCE.
37,
18
(2021)
Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B.
GUT PATHOGENS.
13,
1
(2021)
Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION.
54,
1
(2021)
Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY.
19,
7
(2021)
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.
INFECTION AND CHEMOTHERAPY.
53,
2
(2021)
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study.
MICROORGANISMS.
9,
6
(2021)
Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study.
JOURNAL OF KOREAN MEDICAL SCIENCE.
36,
11
(2021)
PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.
IMMUNITY.
54,
1
(2020)
Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.
JOURNAL OF CLINICAL MEDICINE.
9,
7
(2020)
Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients.
INFECTION AND DRUG RESISTANCE.
13,
1
(2020)
Interim Guidelines on Antiviral Therapy for COVID-19.
Infection and Chemotherapy.
52,
2
(2019)
Possibility of nosocomial person-to-person transmission of hemorrhagic fever with renal syndrome.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY.
40,
11
(2019)
Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.
KOREAN JOURNAL OF INTERNAL MEDICINE.
34,
6
(2019)
Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE.
95,
2
